These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

964 related articles for article (PubMed ID: 27595405)

  • 1. A multifunctional AAV-CRISPR-Cas9 and its host response.
    Chew WL; Tabebordbar M; Cheng JK; Mali P; Wu EY; Ng AH; Zhu K; Wagers AJ; Church GM
    Nat Methods; 2016 Oct; 13(10):868-74. PubMed ID: 27595405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox.
    Senís E; Fatouros C; Große S; Wiedtke E; Niopek D; Mueller AK; Börner K; Grimm D
    Biotechnol J; 2014 Nov; 9(11):1402-12. PubMed ID: 25186301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation.
    Moreno AM; Fu X; Zhu J; Katrekar D; Shih YV; Marlett J; Cabotaje J; Tat J; Naughton J; Lisowski L; Varghese S; Zhang K; Mali P
    Mol Ther; 2018 Jul; 26(7):1818-1827. PubMed ID: 29754775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.
    Hung SS; Li F; Wang JH; King AE; Bui BV; Liu GS; Hewitt AW
    Methods Mol Biol; 2018; 1715():113-133. PubMed ID: 29188510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of AAV Vectors for CRISPR-Mediated In Vivo Genome Editing in the Retina.
    Yu W; Wu Z
    Methods Mol Biol; 2019; 1950():123-139. PubMed ID: 30783971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR Systems Suitable for Single AAV Vector Delivery.
    Stevanovic M; Piotter E; McClements ME; MacLaren RE
    Curr Gene Ther; 2022; 22(1):1-14. PubMed ID: 34620062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining Engineered Nucleases with Adeno-associated Viral Vectors for Therapeutic Gene Editing.
    Epstein BE; Schaffer DV
    Adv Exp Med Biol; 2017; 1016():29-42. PubMed ID: 29130152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR genome engineering and viral gene delivery: a case of mutual attraction.
    Schmidt F; Grimm D
    Biotechnol J; 2015 Feb; 10(2):258-72. PubMed ID: 25663455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome Engineering Using Adeno-associated Virus: Basic and Clinical Research Applications.
    Gaj T; Epstein BE; Schaffer DV
    Mol Ther; 2016 Mar; 24(3):458-64. PubMed ID: 26373345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination.
    Ideno N; Yamaguchi H; Okumura T; Huang J; Brun MJ; Ho ML; Suh J; Gupta S; Maitra A; Ghosh B
    Lab Invest; 2019 Jul; 99(8):1233-1244. PubMed ID: 30728464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Staphylococcus aureus Cas9: a smaller Cas9 for all-in-one adeno-associated virus delivery and paired nickase applications.
    Friedland AE; Baral R; Singhal P; Loveluck K; Shen S; Sanchez M; Marco E; Gotta GM; Maeder ML; Kennedy EM; Kornepati AV; Sousa A; Collins MA; Jayaram H; Cullen BR; Bumcrot D
    Genome Biol; 2015 Nov; 16():257. PubMed ID: 26596280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV mediated genome engineering with a bypass coagulation factor alleviates the bleeding phenotype in a murine model of hemophilia B.
    Sarangi P; Kumar N; Sambasivan R; Ramalingam S; Amit S; Chandra D; Jayandharan GR
    Thromb Res; 2024 Jun; 238():151-160. PubMed ID: 38718473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome Editing of Murine Liver Hepatocytes by AAV Vector-Mediated Expression of Cas9 In Vivo.
    Kashiwakura Y; Ohmori T
    Methods Mol Biol; 2023; 2637():195-211. PubMed ID: 36773148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9.
    Li A; Tanner MR; Lee CM; Hurley AE; De Giorgi M; Jarrett KE; Davis TH; Doerfler AM; Bao G; Beeton C; Lagor WR
    Mol Ther; 2020 Jun; 28(6):1432-1441. PubMed ID: 32348718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of acquired sensorineural hearing loss in mice by in vivo Htra2 gene editing.
    Gu X; Wang D; Xu Z; Wang J; Guo L; Chai R; Li G; Shu Y; Li H
    Genome Biol; 2021 Mar; 22(1):86. PubMed ID: 33752742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A truncated reverse transcriptase enhances prime editing by split AAV vectors.
    Gao Z; Ravendran S; Mikkelsen NS; Haldrup J; Cai H; Ding X; Paludan SR; Thomsen MK; Mikkelsen JG; Bak RO
    Mol Ther; 2022 Sep; 30(9):2942-2951. PubMed ID: 35808824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of CRISPR/Cas9 system by AAV as vectors for gene therapy.
    Wang Y; Jiang H; Li M; Xu Z; Xu H; Chen Y; Chen K; Zheng W; Lin W; Liu Z; Lin Z; Zhang M
    Gene; 2024 Nov; 927():148733. PubMed ID: 38945310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-orthogonal orthologues of AAV capsids and of Cas9 circumvent the immune response to the administration of gene therapy.
    Moreno AM; Palmer N; Alemán F; Chen G; Pla A; Jiang N; Leong Chew W; Law M; Mali P
    Nat Biomed Eng; 2019 Oct; 3(10):806-816. PubMed ID: 31332341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors.
    Bak RO; Porteus MH
    Cell Rep; 2017 Jul; 20(3):750-756. PubMed ID: 28723575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.